Design
Review
No takes yet. Share an insight, caveat, or question.
AT1/AT2 distinctions guide current Ang II-targeted therapies; leaves open AT2-specific interventions in cardiovascular disease.
Dinh et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: